SCHEMBL178518

SCHEMBL178518

COc1cccc(C2=NOC3(CCC4(CC3)OCCO4)C2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
HTT P42858 3/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
KDM4E B2RXH2 4/20 0.44
HPGD P15428 3/20 0.44
CYP1A2 P05177 3/20 0.44
CYP3A4 P08684 3/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 3/20 0.44
MAPT P10636 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
GAA P10253 1/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL178535 0.87 ALDH1A1 (0.40) ALDH1A1HTTNPC1RAB9AKDM4E
SCHEMBL2208887 0.85 CHRNB4 (0.45) ALDH1A1HTTNPC1RAB9AKDM4E
SCHEMBL178540 0.84 SMN1; SMN2 (0.41) ALDH1A1HTTNPC1RAB9AKDM4E
SCHEMBL12904308 0.81 MIF (0.43) ALDH1A1HTTNPC1RAB9AKDM4E
SCHEMBL10226129 0.81 CA1 (0.47) ALDH1A1HTTNPC1RAB9AKDM4E
SCHEMBL10227364 0.81 KIF11 (0.38) ALDH1A1HTTNPC1RAB9AKDM4E
SCHEMBL178532 0.81 CHRNB4 (0.37) ALDH1A1HTTNPC1RAB9AKDM4E
SCHEMBL178519 0.81 CHRNB4 (0.37) ALDH1A1HTTNPC1RAB9AKDM4E
SCHEMBL178521 0.79 CLK4 (0.38) BACE1
SCHEMBL178562 0.78 NOTUM (0.36) HTTNPC1RAB9ACYP2C9BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120059015-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS AS MGLU5 ANTAGONISTS RECORDATI IRELAND LTD. (IT) 2012-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059015-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS AS MGLU5 ANTAGONISTS GRM5, GPR65, GRIK5 ALDH1A1 1514/4885HTT 1186/4885NPC1 1734/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.